Gene · 3691
Papers3,577
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,577
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced ZBTB10 expression induced by betulinic acid inhibits gastric cancer progression by inactivating the ARRDC3/ITGB4/PI3K/AKT pathway. | Cell Oncol (Dordr) | 2025 | 39873948 | PubTator, text mining | PubMed |
| Modeling the lymph node stromal cells in oral squamous cell carcinoma: insights into the stromal cues in nodal metastasis. | Hum Cell | 2025 | 39760828 | PubTator, text mining | PubMed |
| Blue light promotes conjunctival epithelial-mesenchymal transition and collagen deposition through ITGB4. | Ecotoxicol Environ Saf | 2025 | 39732060 | PubTator, text mining | PubMed |
| Alterations in the microenvironment of junctional epidermolysis bullosa keratinocytes: A gene expression study. | Matrix Biol | 2025 | 39615637 | PubTator, text mining | PubMed |
| Up-regulated ITGB4 promotes hepatocellular carcinoma metastasis by activating hypoxia-mediated glycolysis and cancer-associated fibroblasts. | Eur J Pharmacol | 2025 | 39603378 | PubTator, text mining | PubMed |
| Energy Metabolism Dysregulation in Myocardial Infarction: An Integrative Analysis of Ischemic Cardiomyopathy. | Curr Vasc Pharmacol | 2025 | 39069811 | PubTator, text mining | PubMed |
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid'. | J Eur Acad Dermatol Venereol | 2025 | 38940488 | PubTator, text mining | PubMed |
| Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling. | Mol Biotechnol | 2025 | 38332433 | PubTator, text mining | PubMed |
| Hierarchical learning of gastric cancer molecular subtypes by integrating multi-modal DNA-level omics data and clinical stratification. | Quant Biol | 2024 | 41676365 | PubTator, text mining | PubMed |
| Integrin α6 and integrin β4 in exosomes promote lung metastasis of colorectal cancer. | J Cancer Res Ther | 2024 | 39792419 | PubTator, text mining | PubMed |
| ITGB4/CD104 mediates zika virus attachment and infection. | Nat Commun | 2024 | 39737945 | PubTator, text mining | PubMed |
| Cilengitide sensitivity is predicted by overall integrin expression in breast cancer. | Breast Cancer Res | 2024 | 39707454 | PubTator, text mining | PubMed |
| MFAP2 upregulation promotes ESCC metastasis via FAK-AKT signaling pathway. | FASEB J | 2024 | 39698924 | PubTator, text mining | PubMed |
| Nanoscale Morphologies on the Surface of Substrates/Scaffolds Enhance Chondrogenic Differentiation of Stem Cells: A Systematic Review of the Literature. | Int J Nanomedicine | 2024 | 39634196 | PubTator, text mining | PubMed |
| Identification of Biomarkers Associated with Oxidative Stress in Aortic Dissection Based on Bulk Transcriptome Analyses. | Int J Gen Med | 2024 | 39628979 | PubTator, text mining | PubMed |
| Ocular Mucous Membrane Pemphigoid Demonstrates a Distinct Autoantibody Profile from Those of Other Autoimmune Blistering Diseases: A Preliminary Study. | Antibodies (Basel) | 2024 | 39584991 | PubTator, text mining | PubMed |
| Case Report: Alpha6 Integrin Disorder Presenting in Childhood with Nail Dysplasia and Onycholysis But No History of Fragile or Bullous Skin Changes. | Glob Med Genet | 2024 | 39583125 | PubTator, text mining | PubMed |
| ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states. | iScience | 2024 | 39555401 | PubTator, text mining | PubMed |
| Retraction Note: ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial-mesenchymal transition in hepatocellular carcinoma. | Cancer Cell Int | 2024 | 39529135 | PubTator, text mining | PubMed |
| Integrin α6β4 Upregulates PTPRZ1 Through UCHL1-Mediated Hif-1α Nuclear Accumulation to Promote Triple-Negative Breast Cancer Cell Invasive Properties. | Cancers (Basel) | 2024 | 39518121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3691/papers?page=7